E2

When diabetes tech fails, personalised care fails with it

Japan Approves MRD Testing. Price Will Decide Whether Patients Can Use It.

Diphtheria Came Back. Remote Communities Are Carrying the Cost.

Heart pumps save lives. FDA’s latest Impella alerts show why cardiac device safety cannot stop at approval.

Gene therapy is entering cardiology. Friedreich ataxia shows why rare heart disease may be the first test

When Brain Surgery Is Too Risky, Patients Still Need a Molecular Answer

Kenya Moves to Keep Cancer From Bankrupting Families

Before a TB Vaccine Exists, Africa Is Building the Route to People

A Year of Measles in Utah Is What Lost Protection Looks Like
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
